Therefore, an inferior CD69+CD103+ TRM response underpins loss of heterosubtypic immunity in the lung and raises the question of why long-lived, stable TRM does not form in the lung following respiratory infection. This evidence concerns the gene CD69 and respiratory tract infectious disorder.